All data are available at: <https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2011> (NHANES 2011-2012) and <https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2013> (NHANES 2013-2014).

Introduction {#sec001}
============

Toxocariasis has been identified as the most common human parasitic worm infection in the world and one of the most common neglected infections of poverty in the U.S. \[[@pntd.0005818.ref001]--[@pntd.0005818.ref003]\]. Spread through contact with soil contaminated by embryonated eggs from dog and cat feces, the etiologic agents, *Toxocara canis* and *T*. *cati*, have classically been associated with two major clinical syndromes: visceral larva migrans and ocular larva migrans \[[@pntd.0005818.ref004], [@pntd.0005818.ref005]\]. Following accidental ingestion, *Toxocara* spp. larvae migrate to various organs including the lungs, liver and eyes producing an inflammatory response leading to manifestations of disease. Subclinical infection (also called "covert" or "common" toxocariasis) can occur, with some studies suggesting associations with decreased cognitive function, asthma and atopic disease \[[@pntd.0005818.ref006]--[@pntd.0005818.ref009]\].

As soil contamination with embryonated eggs can persist for years and remain infective, human exposure often results from contact with feces-contaminated soil from dogs and cats \[[@pntd.0005818.ref010]\]. The potential for exposure is increased further through various reservoirs for *Toxocara* spp. including intestinal infections and somatic larvae in definitive hosts as well as larvae in paratenic hosts. There is also evidence of eggs found on the hair of definitive hosts such as dogs and cats which may then be transferred to their owners, albeit rarely \[[@pntd.0005818.ref011]\]. Currently, control efforts are focused on removal of pet feces and covering sand pits in recreational areas such as parks and playgrounds and elimination of adult worms in these companion animals to limit risk of transmission from pets to humans \[[@pntd.0005818.ref012]--[@pntd.0005818.ref016]\].

To better define the extent of the problem, serological data from over 20,000 samples were tested via enzyme immunoassay in the Third National Health and Nutrition Examination Survey (NHANES III; 1988--1994) and revealed a seroprevalence of 13.9% for *Toxocara* antibodies \[[@pntd.0005818.ref017]\]. Higher rates of antibody positivity were noted in children, non-Hispanic Blacks, low education/socioeconomic status and in those living in the South or Northeast areas of the U.S.; the primary influences were non-Hispanic Black ethnicity and county poverty \[[@pntd.0005818.ref018]\]. Additional studies have also confirmed the disproportionate burden in those of lower education and socioeconomic status \[[@pntd.0005818.ref002], [@pntd.0005818.ref019], [@pntd.0005818.ref020]\]. Given an increase in the numbers of dogs and cats of approximately 60 and 50%, respectively, from NHANES III (1988--1994) to prior to the current study time-period (2011--2014) as well as the availability of an improved testing platform using a Luminex based assay to rTc-CTL-1 antigen for *Toxocara* spp., we sought to use the latest NHANES data from 2011--2014 to reassess the seroprevalence of *Toxocara* antibody positivity in the U.S. as well as trends in exposure risk groups \[[@pntd.0005818.ref017], [@pntd.0005818.ref021]--[@pntd.0005818.ref024]\].

Materials and methods {#sec002}
=====================

Study design and population {#sec003}
---------------------------

The NHANES is a series of ongoing cross-sectional surveys conducted by the Centers for Disease Control and Prevention (CDC) and is designed to assess the health and nutritional status of Americans through physical examinations and interviews \[[@pntd.0005818.ref025]\]. Individuals in the survey participate in a household interview followed by physical examination in a mobile examination center. The NHANES sampling procedure is a complex multistage probability cluster design which oversamples specific populations such as Hispanics, non-Hispanic blacks, non-Hispanic Asians, older adults, and low income persons to obtain both adequate samples for meaningful subgroup analyses and more reliable parameter estimates \[[@pntd.0005818.ref026]\].

The survey's design and weighting methodology have previously been described \[[@pntd.0005818.ref027]\]. To account for unequal selection probabilities among participants and adjustments for non-response, all estimates were weighted using multi-year sampling weights calculated from those provided by the National Center for Health Statistics (NCHS) to account for the two combined 2011--2012 and 2013--2014 NHANES cycles \[[@pntd.0005818.ref028]\]. The data collection protocol was approved by the NCHS institutional review board.

Demographic data and characteristics {#sec004}
------------------------------------

Demographic information was obtained during the household interview. Self-reported socio-demographic characteristics included age at the time of the survey. Participants aged 6 to 17 were classified as children and those 18 years and older were classified as adults. Additional factors include gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, or other including multiracial), marital status (married or member of an unmarried couple; divorced, widowed, or separated; and never married), education level (did not graduate high school, graduated high school or attained a GED, some college or technical school, and graduated from college or technical school), health insurance coverage status, history of asthma, and family Poverty to Income Ratio (PIR). Pooling of demographic categories was conducted.

Specimen collection and laboratory methods {#sec005}
------------------------------------------

Sera collected from NHANES 2011--2012 and 2013--2014 participants 6 years and older were tested for *Toxocara* spp. by a Luminex assay using recombinant rTc-CTL-1 antigen that detects IgG antibodies against *Toxocara* spp. The antibody test was classified as positive if the antibody responses to rTc-CTL-1 was greater than the cut-off point value of 23.1 mean fluorescence intensity \[[@pntd.0005818.ref029], [@pntd.0005818.ref030]\]. The assay itself has been validated against reference serum and has a sensitivity of 90% and a specificity of 99% \[[@pntd.0005818.ref023]\].

Statistical analysis {#sec006}
--------------------

Analyses were conducted using NHANES provided statistical weights to account for the complex survey design. Weighted prevalence estimates are reported as percentages with 95% Wald confidence intervals (CI). Categorical variables were analyzed using Rao-Scott adjusted chi-square tests. Multivariable analysis was performed using logistic and linear regression models to determine predictors of *Toxocara* spp. infection. All statistical tests were performed by using a P \< 0.05 level of significance. Data analyses were conducted using the complex sample package for SPSS 23 (IBM, Armonk, NY, USA).

Ethics statement {#sec007}
----------------

Per NCHS standards, all adult participants provide written informed consent and for children \<18 years of age, written informed consent by both the child and the parent/guardian was required. For this study, a waiver was obtained from the Womack Army Medical Center Institutional Review Board in accordance with the use of publicly available de-identified data.

Results {#sec008}
=======

A total of 13,509 individuals with valid *Toxocara* spp. antibody results participated in both the interview and examination portion of the 2011--2014 NHANES. The sample included 15.2% (N = 3,337) children and 84.8% (N = 10,172) adults. Overall, 858 (5.1%; 95% CI 4.4--5.9) participants tested positive for the *Toxocara* spp. antibody, representing over 12 million people in the greater non-institutionalized US population. Demographic and socioeconomic characteristics of children and adults are shown in Tables [1](#pntd.0005818.t001){ref-type="table"} and [2](#pntd.0005818.t002){ref-type="table"} respectively.

10.1371/journal.pntd.0005818.t001

###### Characteristics associated with *Toxocara* spp. infection in children.

![](pntd.0005818.t001){#pntd.0005818.t001g}

                                                                            *Toxocara* spp. Positive              *Toxocara* spp. Negative   OR (95% CI)[^1^](#t001fn001){ref-type="table-fn"}                                            
  ------------------------------------------------------------------------- ------------------------------------- -------------------------- --------------------------------------------------- -------------------- ------------------- ------------------------------------------
  Sample Size                                                               131                                   3.6 (2.7--4.7)             3206                                                96.4 (95.3--97.3)                        
  Age group, yrs                                                                                                                                                                                                                          
                                                                            6--9                                  37                         2.6 (1.6--4.0)                                      1112                 97.4 (96.0--98.4)   NS[^2^](#t001fn002){ref-type="table-fn"}
                                                                            10--13                                45                         3.9 (2.7--5.6)                                      1079                 96.1 (94.4--97.3)   
                                                                            14--17                                49                         4.1 (2.8--5.9)                                      1015                 95.9 (94.1--97.2)   
  Gender                                                                                                                                                                                                                                  
                                                                            Male                                  75                         4.0 (2.8--5.5)                                      1644                 96.0 (94.5--97.2)   NS[^2^](#t001fn002){ref-type="table-fn"}
                                                                            Female                                56                         3.2 (2.2--4.6)                                      1562                 96.8 (95.4--97.8)   
  Race/Ethnicity                                                                                                                                                                                                                          
                                                                            Non-Hispanic white                    29                         3.1 (2.0--4.7)                                      804                  95.9 (95.3--98.0)   NS[^2^](#t001fn002){ref-type="table-fn"}
                                                                            Non-Hispanic black                    38                         4.7 (3.2--6.8)                                      832                  95.3 (93.2--96.8)   
                                                                            Hispanic                              48                         4.5 (2.8--7.0)                                      1061                 95.5 (93.0--97.2)   
                                                                            Other race, including multicultural   16                         2.7 (1.7--4.2)                                      509                  97.3 (95.8--98.3)   
  Health Insurance                                                                                                                                                                                                                        
                                                                            Covered                               107                        3.2 (2.4--4.3)                                      2890                 96.8 (95.7--97.6)   1 (Reference)
                                                                            No Health Insurance                   23                         7.3 (4.6--11.6)                                     313                  92.7 (88.4--95.4)   2.4 (1.4--4.2)
  Asthma History                                                                                                                                                                                                                          
                                                                            Yes                                   26                         3.4 (2.1--5.6)                                      631                  96.6 (94.4--97.9)   NS[^2^](#t001fn002){ref-type="table-fn"}
                                                                            No                                    105                        3.6 (2.7--4.8)                                      2574                 96.4 (95.2--97.3)   
  Ratio of family income to poverty[^3^](#t001fn003){ref-type="table-fn"}                                                                                                                                                                 
                                                                            Below federal poverty level           55                         4.9 (3.1--7.7)                                      1034                 95.1 (92.3--96.9)   NS[^2^](#t001fn002){ref-type="table-fn"}
                                                                            At or above federal poverty level     66                         2.9 (2.1--4.2)                                      1985                 97.1 (95.8--97.9)   

^1^ Odds Ratio based on regression analysis of 3333 participants with complete data.

^2^ NS: Non Significant.

^3^ Subsample does not sum to total sample due to non-responses.

10.1371/journal.pntd.0005818.t002

###### Characteristics associated with *Toxocara* spp. infection in adults.

![](pntd.0005818.t002){#pntd.0005818.t002g}

                                                                            *Toxocara* spp. Positive                  *Toxocara* spp. Negative   aOR (95% CI)[^1^](#t002fn001){ref-type="table-fn"}                                           
  ------------------------------------------------------------------------- ----------------------------------------- -------------------------- ---------------------------------------------------- ------------------- ------------------- ------------------------------------------
  Sample Size                                                               727                                       5.3 (4.6--6.2)             9445                                                 94.7 (93.8--95.4)                       
  Age group, yrs                                                                                                                                                                                                                              
                                                                                18--29                                107                        4.4 (3.4--5.8)                                       2053                95.6 (94.2--96.6)   NS[^2^](#t002fn002){ref-type="table-fn"}
                                                                                30--39                                92                         4.8 (3.8--6.0)                                       1594                95.2 (94.0--96.2)   
                                                                                40--49                                116                        5.4 (4.3--6.8)                                       1529                94.6 (93.2--95.7)   
                                                                                50--59                                130                        6.4 (4.8--8.6)                                       1462                93.6 (91.4--95.2)   
                                                                                60+                                   282                        5.7 (4.5--7.0)                                       2807                94.3 (93.0--95.5)   
  Gender                                                                                                                                                                                                                                      
                                                                                Male                                  442                        6.8 (5.9--7.9)                                       4489                93.2 (92.1--94.1)   1.9 (1.5--2.3)
                                                                                Female                                285                        4.0 (3.2--4.9)                                       4956                96.0 (95.1--96.8)   1 (Reference)
  Race/Ethnicity                                                                                                                                                                                                                              
                                                                                Non-Hispanic white                    194                        3.9 (3.1--4.9)                                       3945                96.1 (95.1--96.9)   1 (Reference)
                                                                                Non-Hispanic black                    181                        7.2 (5.8--8.8)                                       2063                92.8 (91.2--94.2)   1.5 (1.1--2.1)
                                                                                Hispanic                              226                        9.8 (7.6--12.6)                                      2001                90.2 (87.4--92.4)   1.6 (1.1--2.4)
                                                                                Other race, including multicultural   126                        7.0 (5.7--8.7)                                       1436                93.0 (91.3--94.3)   1.8 (1.3--2.5)
  Marital Status[^3^](#t002fn003){ref-type="table-fn"}                                                                                                                                                                                        
                                                                                Married or living with partner        411                        5.2 (4.4--6.1)                                       5209                94.8 (93.9--95.6)   
                                                                                Widowed, divorced, or separated       178                        6.4 (5.0--8.0)                                       1940                93.6 (92.0--95.0)   NS[^2^](#t002fn002){ref-type="table-fn"}
                                                                                Never married                         114                        5.2 (3.9--6.9)                                       1793                94.8 (93.1--96.1)   
  Education[^3^](#t002fn003){ref-type="table-fn"}                                                                                                                                                                                             
                                                                                Less than high school graduate        279                        11.5 (9.6--13.6)                                     1859                88.5 (86.4--90.4)   2.7 (1.9--3.7)
                                                                                High school graduate or GED           176                        7.2 (5.9--8.8)                                       1891                92.8 (91.2--94.1)   2.1 (1.5--2.9)
                                                                                Some college                          145                        3.8 (2.9--4.9)                                       2830                96.2 (95.1--97.1)   NS[^2^](#t002fn002){ref-type="table-fn"}
                                                                            College graduate                          103                        2.9 (2.3--3.7)                                       2359                97.1 (96.3--97.7)   1 (Reference)
  Health Insurance[^3^](#t002fn003){ref-type="table-fn"}                                                                                                                                                                                      
                                                                                Covered                               475                        4.3 (3.7--5.0)                                       7410                95.7 (95.0--96.3)   1 (Reference)
                                                                                No Health Insurance                   252                        9.9 (7.9--12.2)                                      2024                90.1 (87.8--92.1)   1.5 (1.1--1.9)
  Asthma History[^3^](#t002fn003){ref-type="table-fn"}                                                                                                                                                                                        
                                                                                Yes                                   89                         4.7 (3.6--6.0)                                       1469                95.3 (94.0--96.4)   NS[^2^](#t002fn002){ref-type="table-fn"}
                                                                                No                                    638                        5.5 (4.7--6.4)                                       7968                94.5 (93.6--95.3)   
  Ratio of family income to poverty[^3^](#t002fn003){ref-type="table-fn"}                                                                                                                                                                     
                                                                                Below federal poverty level           251                        10.8 (8.9--13.0)                                     2034                89.2 (87.0--91.1)   1.8 (1.4--2.3)
                                                                                At or above federal poverty level     408                        4.2 (3.6--4.8)                                       6685                95.8 (95.2--96.4)   1 (Reference)

^1^ Adjusted Odds Ratio based on multiple regression analysis of 8901 participants with complete data.

^2^ NS: Non Significant.

^3^ Subsample does not sum to total sample due to non-responses.

The prevalence of *Toxocara* spp. antibody for adults revealed no significant change in prevalence between the data collection cycles. In contrast, children experienced a significant reduction between 2011--2012 and 2013--2014 (P \< 0.01). This was primarily associated with a decrease in prevalence among children with health insurance (P \< 0.01, see [Table 3](#pntd.0005818.t003){ref-type="table"}); there was no difference in health care utilization.

10.1371/journal.pntd.0005818.t003

###### *Toxocara* spp. antibody prevalence by time.

![](pntd.0005818.t003){#pntd.0005818.t003g}

                                           2011--2012                           2013--2014         *P* [^1^](#t003fn001){ref-type="table-fn"}                     
  ---------------------------------------- ------------------------------ ----- ------------------ -------------------------------------------- ----------------- ---------
  Children with Positive Antibody Result                                                                                                                          
                                               With Health Insurance      81    4.5 (3.0--6.5)     26                                           1.7 (1.1--2.7)    \<0.01 
                                               Without Health Insurance   15    8.7 (5.0--14.8)    8                                            5.3 (2.1--12.4)   0.32
                                           Total                          96    4.9 (3.4--7.0)     34                                           2.0 (1.4--2.9)    \<0.01 
  Adults with Positive Antibody Result                                                                                                                            
                                               With Health Insurance      248   4.6 (3.8--5.6)     227                                          4.0 (3.2--5.0)    0.30
                                               Without Health Insurance   142   10.5 (8.2--13.3)   110                                          9.1 (6.2--13.3)   0.54
                                               Total                      390   5.8 (4.8--7.0)     337                                          4.9 (3.8--6.2)    0.27

^1^ P value based on Rao-Scott adjusted chi-square statistic.

Multivariable analysis of socio-demographic factors in adults identified the following risk factors for infection: gender (P \< 0.001), race/ethnicity (P = 0.01), education (P \< 0.001), healthcare coverage (P \< 0.01), and PIR (P \< 0.001). There was no significant difference between infection groups with regard to age category, marital status, or asthma diagnosis. Infection prevalence was higher among males compared to females and among non-White ethnicities. Additionally, the lack of health insurance and education was also associated with higher levels of infection among adults. Among children, only health insurance status distinguished seropositivity between the two groups (P \< 0.01).

[Table 4](#pntd.0005818.t004){ref-type="table"} shows laboratory results by *Toxocara* spp. seroprevalence and age category. Seropositive and seronegative children had a median blood lead concentrations of 0.98 (IQR 0.50--1.46) ug/dL and 0.53 (IQR 0.40--0.76) ug/dL, respectively (P \< 0.01); median urinary lead concentrations were 0.50 (IQR 0.26--0.83) ug/dL and 0.26 (IQR 0.14--0.47) ug/dL, respectively (P \< 0.01).

10.1371/journal.pntd.0005818.t004

###### Laboratory values by *Toxocara* antibody results.

![](pntd.0005818.t004){#pntd.0005818.t004g}

                                   Toxocara Positive   Toxocara Negative          *P*[^1^](#t004fn001){ref-type="table-fn"}                             
  --------------------- ---------- ------------------- -------------------------- ------------------------------------------- ------------------------- ---------
  Lead, urine (ug/L)                                                                                                                                    
                        Adults     234                 0.40 (0.20--0.66)          3082                                        0.33 (0.18--0.59)         0.37
                        Children   37                  0.50 (0.26--0.83)          1025                                        0.26 (0.14--0.47)         \<0.01
  Lead, blood (ug/dL)                                                                                                                                   
                        Adults     560                 1.24 (0.81--1.96)          7091                                        0.98 (0.63--1.54)         \<0.01
                        Children   120                 0.98 (0.50--1.46)          2831                                        0.53 (0.40--0.76)         \<0.01
  Hemoglobin (g/dL)                                                                                                                                     
                        Adults     727                 14.40 (13.40--15.20)       9436                                        14.10 (13.20--15.10)      0.10
                        Children   131                 13.50 (12.90--14.50)       3204                                        13.50 (12.80--14.20)      0.75
  Hematocrit (%)                                                                                                                                        
                        Adults     727                 42.20 (39.20--44.60)       9436                                        41.4 (38.70--44.20)       0.01
                        Children   131                 39.50 (37.60--42.10)       3204                                        39.40 (37.40--41.60)      0.90
  RBC Folate (ng/mL)                                                                                                                                    
                        Adults     390                 411.00 (312.10--512.10)    4712                                        476.80 (359.40--618.10)   \<0.001
                        Children   97                  4445.90 (312.10--525.40)   1663                                        450.30 (368.20--547.50)   0.18
  TSH (mIU/L)                                                                                                                                           
                        Adults     125                 1.49 (1.16--2.00)          1563                                        1.58 (1.10--2.28)         0.16
                        Children   16                  1.16 (0.93--1.62)          252                                         1.49 (0.99--1.95)         0.08

^1^ P value based on adjusted Rao-Scott chi-square statistic.

Seropositive adults also had elevated serum lead levels compared to non-infected adults with a median of 1.24 (IQR 0.81--1.96) ug/dL vs. 0.98 (0.63--1.54) ug/dL (P \<0.01), but urinary lead levels were not significantly different. Additionally, eosinophilia (defined as ≥ 500 eosinophils/uL) was present in 8.8% (95% CI, 6.1--12.5) of seropositive adults versus 5.2% (95% CI, 4.6--5.9) of seronegative adults (OR 1.7; 95% CI 1.2--2.5). No similar difference in eosinophilia was noted among children.

Discussion {#sec009}
==========

Relative to NHANES III (1988--1994), current U.S. data show an overall decrease in *Toxocara* spp. seroprevalence from 13.9% to 5.1%. This may be related to changes in exposure, a more specific testing platform, and perhaps modifications in veterinary practices and awareness \[[@pntd.0005818.ref017], [@pntd.0005818.ref031]\]. Seroprevalence remains elevated in certain groups such as minority ethnic groups, male gender and those with low education and socioeconomic status. Despite an overall decrease, this study of a nationally representative sample highlights the continued exposure of the U.S. population to this disease and the persistent disparities associated with at-risk populations.

Similar to the previous seroprevalence study utilizing data obtained over 20 years ago, we showed a persistent elevation in odds of antibody positivity in adults among minority ethnicity, male gender and low education level \[[@pntd.0005818.ref017]\]. These findings overall mirror those found by Congdon et al. demonstrating minority ethnicity and poverty were important drivers of higher levels of *Toxocara* antibody positivity \[[@pntd.0005818.ref008], [@pntd.0005818.ref018]\]. Conversely, with non-Hispanic white as the reference, we found Hispanic and other race/multicultural ethnicities to have a higher risk of exposure than non-Hispanic Black. This is different than the studies by Won et al. and Congdon et al., which suggested lower rates of exposure in the Hispanic population \[[@pntd.0005818.ref017], [@pntd.0005818.ref018]\]. It has been hypothesized that the lower rates in Hispanic populations may be related to residence in more arid Western states with less likelihood for exposure to viable *Toxocara* eggs \[[@pntd.0005818.ref019]\]. Unfortunately, no data were available in our study for region of the country or rural versus urban environment. Non-college level education (surrogate for lower socioeconomic status) and male gender have also previously been associated with increased *Toxocara* antibody positivity and were identified in this study as well \[[@pntd.0005818.ref017], [@pntd.0005818.ref032]\]. Although previously reported, age did not appear to be a risk factor for this cohort \[[@pntd.0005818.ref017], [@pntd.0005818.ref033]\].

For children, no difference was found in demographic data despite looking at multiple variables including age, gender, socioeconomic status and ethnicity. Additional factors that have previously been associated such as a diagnosis of asthma and eosinophilia were also not significantly different \[[@pntd.0005818.ref008], [@pntd.0005818.ref034]\]. Interestingly, a protective effect of health insurance was noted. Typically, antibody positivity might reflect lower socio-economic status, however in our study, a child's family PIR was not a significant determinant of infectivity \[[@pntd.0005818.ref035]\]. Furthermore, health care utilization rates did not differ between those with and without *Toxocara* infection.

From a testing standpoint, an additional consideration between NHANES III and the current data is the change in the testing platform itself. For NHANES III, seroprevalence was determined using *Toxocara canis* excretory secretory antigen enzyme immunoassay testing (TES-Ag EIA). Although this test has been the standard worldwide, the sensitivity is as low as 78% (for visceral larva migrans) and specificity has been limited by cross-reactivity, particularly in areas with other soil-transmitted helminthes such as *Ascaris* spp. \[[@pntd.0005818.ref036]\]. Based on a review from 2014, prevalence of potential cross- reacting parasites such as *Ascaris* spp. may be as high as 49.4%, with higher rates in the southern U.S. and Appalachian regions \[[@pntd.0005818.ref037]\]. Given this, results from prior seroprevalence studies may overestimate *Toxocara* exposure risk \[[@pntd.0005818.ref001], [@pntd.0005818.ref038]\]. For the most recent data, a newer assay based on rTc-CTL-1 antigen to *Toxocara* spp. was used with a sensitivity and specificity of 90% and 99%, respectively \[[@pntd.0005818.ref023]\]. Thus, the current NHANES data likely is a better reflection of *Toxocara* exposure.

For the risk of exposure itself, the overall number of dogs and cats is an important factor. As mentioned previously, U.S. pet ownership has steadily increased from approximately 52 million dogs and 54 million cats at the time of NHANES III (1988--1994) to an estimated 70--83 million dogs and 74--96 million cats just prior to the current study time-period (2011--2014) \[[@pntd.0005818.ref021], [@pntd.0005818.ref022], [@pntd.0005818.ref024]\]. As *Toxocara* spp. eggs are transmitted to the soil through dog and cat feces, the CDC encourages routine evaluation and treatment of house pets to limit human exposure as well as removal of any pet feces from recreational areas \[[@pntd.0005818.ref039]\]. Household gardens have also been shown to have high levels of *Toxocara* ova, suggesting use of gloves during gardening activities may help decrease risk for exposure \[[@pntd.0005818.ref040]\]. In addition, the Companion Animal Parasite Council suggests year round treatment for control of intestinal parasites \[[@pntd.0005818.ref041]\]. At least one study suggests this therapy can reduce intestinal parasites by up to 91% in pet dogs when compared to shelter dogs, although there was no direct analysis of treated versus untreated dogs to rule out confounders such as decreased exposure between these two groups \[[@pntd.0005818.ref031]\]. Prior studies have shown treatment must be provided at least four times per year for efficacy \[[@pntd.0005818.ref042]\]. Unfortunately, as was demonstrated in a Dutch cohort of pet owners, as few as 16% of pet dogs and 24.5% of pet cats were at this goal; no similar studies were found in the U.S. \[[@pntd.0005818.ref042], [@pntd.0005818.ref043]\]. Additionally, in a study performed in Ireland, only 51.7% of pet owners believed pet feces could pose a risk to human health and only 4.3% had heard of *Toxocara* infection, potentially accounting for the low adherence to treatment recommendations \[[@pntd.0005818.ref044]\]. With regards to prevention of environmental exposure, a study from Poland revealed continued high levels of soil contamination with *Toxocara* spp. eggs, particularly in backyards of rural and urban areas highlighting the fact that current preventive efforts may have limited efficacy; no similar studies were found in the U.S. \[[@pntd.0005818.ref045]\].

Finally, as exposure to environmental lead and *Toxocara* spp. can both occur from exposure to contaminated soil, elevated lead levels are frequently found in *Toxocara* seropositive patients \[[@pntd.0005818.ref017], [@pntd.0005818.ref046]\]. In this study, blood lead levels showed a statistically significant difference between seropositive and seronegative adults. For adults, occupational exposure (particularly construction and manufacturing work) accounts for over 60% of lead exposure in those found to have very high blood levels \[[@pntd.0005818.ref047]\]. As these occupations may be associated with increased dust, soil and outdoor exposure this may provide a link with infection. However, the data are conflicting on occupational exposure with at least one study of gardeners failing to show an increased risk whereas increased seroprevalence has been noted in waste pickers and those engaged in agricultural work \[[@pntd.0005818.ref017], [@pntd.0005818.ref020], [@pntd.0005818.ref048], [@pntd.0005818.ref049]\]. Occupational information was not available in the 2011--2014 cycle so further comparison could not be made in this study. It is also important to note that while statistically significant differences occurred, blood lead levels noted in those seropositive were considerably less than the CDC reference value of 5 ug/dL.

Other laboratory findings in adults included a lower RBC folate (P \< 0.001) and higher eosinophil count (P \< 0.01) in seropositive samples. Review of the hemoglobin and hematocrit levels between seropositive and seronegative adults did not differ so the significance of a lower RBC folate is likely negligible. Also, although *Toxocara* infection has been associated with atopic diseases (such as asthma) and eosinophilia, no difference was noted for asthma and the absolute difference in eosinophil count noted was minimal and thus not likely to be clinically significant \[[@pntd.0005818.ref050], [@pntd.0005818.ref051]\].

For children, blood and urine lead levels were elevated in those with *Toxocara* antibody positivity, which has been identified in previous studies \[[@pntd.0005818.ref007], [@pntd.0005818.ref017]\]. The concurrent elevation of both *Toxocara* antibody and lead levels is concerning as both have been independently associated with decreased cognitive function in children \[[@pntd.0005818.ref007], [@pntd.0005818.ref017], [@pntd.0005818.ref052]\]. In our study, the mean serum level of 1.43 ug/dl in seropositive children, though statistically higher than those seronegative, was well below the CDC reference level of 5 ug/dL. Despite this cut-off, no "safe" level of blood lead has been identified in children and thus interventions aimed at decreasing the common route of exposure (i.e. geophagy) may help decrease rates of both \[[@pntd.0005818.ref053]--[@pntd.0005818.ref055]\].

Several limitations of this study should be noted. This study did not include children younger than 6 years old. Also, we could not assess the extent to which higher seroprevalence might have reflected birth, prior residence outside the U.S. or current residence. In addition, antibody testing does not distinguish between current and prior infection so higher rates in adults may be related to antibody persistence from infection at a younger age. Although little research has been done, most studies show that antibody positivity tends to wane with time and thus this is unlikely to have impacted our findings \[[@pntd.0005818.ref056]\]. Finally, the use of a different testing platform with increased *Toxocara* sensitivity and specificity may limit the ability to make comparisons between prior reports and current data.

In conclusion, *Toxocara* spp. continues to affect a considerable portion of the U.S. non-institutionalized population and risk for exposure may increase as dogs and cats enter more homes. Significant gaps in research remain, particularly for *Toxocara* spp. contamination in various areas of the U.S. such as public parks, recreational areas and urban vs. rural locales. Studies assessing current CDC recommendations in reducing exposure such as disposal of pet waste and hand washing are also limited. Infection could be decreased with improved awareness in both the general population and U.S. veterinarians of exposure risks and knowledge of the effectiveness of anthelminthic treatment of dogs and cats.
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